SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001558370-23-006895
Filing Date
2023-04-26
Accepted
2023-04-26 17:15:32
Documents
20

Document Format Files

Seq Description Document Type Size
1 DEF 14A iova-20230606xdef14a.htm   iXBRL DEF 14A 1966897
2 GRAPHIC iova-20230606xdef14a_a002.jpg GRAPHIC 15019
3 GRAPHIC iova-20230606xdef14a_a008.jpg GRAPHIC 38039
4 GRAPHIC iova-20230606xdef14a_a019.jpg GRAPHIC 48808
5 GRAPHIC iova-20230606xdef14a_a020.jpg GRAPHIC 40636
6 GRAPHIC iova-20230606xdef14a_bg001.jpg GRAPHIC 234327
7 GRAPHIC iova-20230606xdef14a_bg002.jpg GRAPHIC 155189
  Complete submission text file 0001558370-23-006895.txt   4826723

Data Files

Seq Description Document Type Size
8 EX-101.SCH iova-20230606.xsd EX-101.SCH 5760
9 EX-101.DEF iova-20230606_def.xml EX-101.DEF 7874
10 EX-101.LAB iova-20230606_lab.xml EX-101.LAB 13183
11 EX-101.PRE iova-20230606_pre.xml EX-101.PRE 6870
14 EXTRACTED XBRL INSTANCE DOCUMENT iova-20230606xdef14a_htm.xml XML 553003
Mailing Address 825 INDUSTRIAL ROAD 4TH FLOOR SAN CARLOS CA 94070
Business Address 825 INDUSTRIAL ROAD 4TH FLOOR SAN CARLOS CA 94070 6502607120
IOVANCE BIOTHERAPEUTICS, INC. (Filer) CIK: 0001425205 (see all company filings)

IRS No.: 753254381 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36860 | Film No.: 23850811
SIC: 2836 Biological Products, (No Diagnostic Substances)